DELTA CORP
DELTACORP · NSE
75.88
+5.41 (+7.68%)
as of 29 Oct 2026 close
Open
70.49
High
76.69
Low
70.25
Prev close
70.47
52w high
88.60
06 Oct 2026
52w low
48.30
30 Mar 2026
VWAP
73.96
Delivery %
26.0%
of volume
Volume 46.91 L · turnover ₹34.69 Cr · NSE bhavcopy (official close) · history since 04 Jan 2010
- ISIN
- INE124G01033
- Series
- EQ
- Listed on NSE
- 02 Nov 2007
- Face value
- ₹1
- F&O
- No
Formerly ARROWGROUP (until 11 Dec 2008). Earlier name: Arrow Webtex Limited (until 11 Dec 2008).
Source: NSE equity master · as of 30 Oct 2026
Daily · NSE EOD
Bulk & block deals · NSE daily reports
| 30 Sept 2026 | bulk | CLT RESEARCH TECH PRIVATE LTD | SELL | 14.64 L | 84.67 |
| 30 Sept 2026 | bulk | CLT RESEARCH TECH PRIVATE LTD | BUY | 14.64 L | 84.60 |
| 30 Sept 2026 | bulk | HRTI PRIVATE LIMITED | BUY | 33.23 L | 84.03 |
| 30 Sept 2026 | bulk | HRTI PRIVATE LIMITED | SELL | 34.57 L | 84.22 |
| 30 Sept 2026 | bulk | IMC INDIA SECURITIES PRIVATE LIMITED | SELL | 12.99 L | 85.53 |
| 30 Sept 2026 | bulk | IMC INDIA SECURITIES PRIVATE LIMITED | BUY | 15.59 L | 85.18 |
| 30 Sept 2026 | bulk | JUNOMONETA FINSOL PRIVATE LIMITED | SELL | 31.52 L | 84.75 |
| 30 Sept 2026 | bulk | JUNOMONETA FINSOL PRIVATE LIMITED | BUY | 31.57 L | 84.65 |
Quarterly results · Standalone · latest 30 Sept 2026
filed 19 Oct 2026, 09:53 pm IST| ₹ crore | Sept 26* |
|---|---|
| Revenue | 127 |
| Other income | 4 |
| Total expenses | 97 |
| Operating margin | -65.4% |
| Finance costs | 1 |
| Depreciation | 6 |
| Profit before tax | -86 |
| Tax | -6 |
| Net profit | -80 |
| Net margin | -63.0% |
| EPS (₹) | -2.99 |
Source and definitions
NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.
Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
- P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
- FII / DII / mutual fund split (from shareholding XBRL)
- Peer comparison